Medication Guide 8 min read· 28 October 2026

Generic Semaglutide in India: What the Differences Between Brands Actually Mean

More than 30 brands now sell the same molecule. The differences that matter are not on the price sticker: pen or vial, how the dose steps match your prescription, how the medicine was kept cold on its way to you, and whether you can trace it.

🩺

ALTRcare Medical Team

Clinical Editorial

Medically reviewed by Dr. Mujeeb AfzalMBBS, MD, DM (Endocrinology) · Reg. No. 71516, Telangana State Medical CouncilLast reviewed 28 October 2026How we review our guides
A pharmacist at a pharmacy counter

Every generic semaglutide sold legally in India contains the same active molecule and needs approval from India's drug regulator, so the medicine itself is meant to work the same way whichever company makes it. The differences that matter sit around the molecule: whether it comes as a ready-to-use pen or a vial you draw up with a syringe, whether its dose steps match your prescription, how it was kept cold between the factory and your fridge, and whether you can trace it to a licensed pharmacy with a batch number and an invoice. Price is the least useful way to choose.

Key facts

  • Semaglutide's patent expired in India on 20 March 2026, and several companies launched generics the next day (Business Today).
  • By mid-2026, 35 semaglutide brands from 17 companies were competing in India, according to market tracker Pharmarack (Outlook Business, 29 June 2026).
  • India's revised good manufacturing rules (Schedule M) applied to large drug makers from mid-2024 and to small and medium makers that sought an extension by 31 December 2025 (G.S.R. 922(E), G.S.R. 127(E)).
  • Semaglutide pens are stored at 2 to 8°C before first use and must never be frozen (US prescribing information); CDSCO has warned that pens not kept in proper storage may be compromised (CDSCO alert, August 2025).
  • The US FDA has reported patients injecting five to 20 times the intended dose from multi-dose vials, partly from confusing millilitres, milligrams and units (FDA, July 2024).

Same molecule, same rules

A generic is the same active medicine as the original, made by another company once the patent has expired. In India every brand needs marketing approval from the Central Drugs Standard Control Organisation (CDSCO) before it can be sold, and the factory has to meet India's revised Schedule M good manufacturing practices, which were notified in December 2023 (G.S.R. 922(E)). The Ministry of Health has also made GLP-1 medicines prescription-only by endocrinologists and internal medicine specialists, and by cardiologists for some uses (PIB, March 2026).

Approval is not the end of checking. Drug inspectors test samples from the market, and CDSCO publishes a monthly list of medicines found not of standard quality or spurious, searchable by month and source (CDSCO NSQ alerts). That list is public, and anyone can look up a product or batch on it.

What actually differs between brands

What to compare, and why
DifferenceWhy it mattersWhat to check
Pen or vialA pen sets the dose for you. A vial needs a syringe and careful measuring.Which device your prescription is written for, and who will teach you to use it
Dose stepsYour dose rises in steps. The pen or vial has to deliver each step exactly.That the strengths on offer match every step of your plan
Storage instructionsDifferent products may allow different times out of the fridge.The leaflet in your own pack, not a general rule from the internet
Batch and expiryTraceability if there is ever a quality alert.Batch number and expiry on the carton and the pen match
Steady supplyChanging brand mid-plan can mean a new device to learn.That your pharmacy can supply the same product through your plan
What to compare, and why

Pen or vial

Some makers in India sell semaglutide in multi-dose vials as well as pens (Outlook Business, March 2026). Vials are approved medicines, but they move the measuring job to you. In the US, the FDA received reports of patients drawing five to 20 times the intended dose from multi-dose vials, often because a dose written in "units" on an insulin syringe was misread, for example 50 units instead of 5 (FDA alert). If you are given a vial, ask for the dose in both millilitres and syringe units, and ask to be shown once on a video call before your first injection.

The cold chain: the difference you cannot see

Semaglutide is a peptide medicine that has to be kept cool. The originator's US labels say pens should be kept in the fridge at 2 to 8°C before first use, away from the freezer compartment, never used if they have been frozen, and protected from heat and light; once in use, a multi-dose pen can be kept for up to 56 days at 15 to 30°C or in the fridge (US prescribing information). We could not find publicly posted prescribing information for Indian generics, so follow the leaflet in your own pack rather than assuming these numbers apply.

  • Injectables should arrive in an insulated box with cool packs, and go into your fridge straight away.
  • Do not use a pen that has been frozen, or one left in a hot car or in direct sun.
  • Only use the medicine if the solution is clear, colourless and has no particles (US prescribing information).
  • Never share a pen, even with a new needle.
  • Ask the pharmacy how the medicine was stored and shipped. A good one can tell you.

In August 2025, CDSCO issued an alert after branded semaglutide pens were stolen in transit, warning that their quality "may be compromised if the products are not handled in proper storage conditions" and advising patients to buy only from authorised sources with a proper invoice (CDSCO alert).

Why "which is cheapest" is the wrong question

  • A spoiled or fake pen costs the most. The suspected fake pens seized in Haryana in April 2026 were sold online at about 27% below the genuine price (Reuters via Gulf Daily News). An unusual discount is a warning, not a bargain.
  • Switching brands mid-plan has a cost. A new device, possibly different dose steps, and a new set of instructions in the weeks when your stomach is still adjusting.
  • The benefit lasts only while you take it. The product you can keep getting, reliably and stored properly, for many months matters more than the cheapest box this week. Our guide to coming off without the weight coming back explains why continuity matters.

How to check what you have

  1. 1A prescription in your name from a qualified doctor. See how to get one online, legally.
  2. 2An invoice from a licensed pharmacy, with the product name, batch number and expiry.
  3. 3The batch number and expiry on the carton match those on the pen or vial.
  4. 4Cold packaging on arrival, and the pack sealed and undamaged.
  5. 5If in doubt, look up the product on CDSCO's monthly not-of-standard-quality list, and ask your doctor before injecting.

Start with the right questions

A doctor reviews your health first and explains every choice in your plan, including the device and how it reaches you. It starts with a 2-minute eligibility check.

Frequently asked questions

Is generic semaglutide the same as the original?

It contains the same active molecule and must be approved by India's drug regulator, CDSCO, before it can be sold. What can differ is the device (pen or vial), the dose strengths on offer, the storage instructions and how carefully it was handled before it reached you.

Which generic semaglutide brand is best in India?

There is no single best brand. Choose with your doctor based on whether the device and dose steps match your plan, whether your pharmacy can supply it steadily, and whether it comes from a licensed pharmacy with an invoice and cold-chain packaging.

Is a semaglutide pen or vial better?

Both can be approved medicines, but a pen sets the dose for you, while a vial needs you to measure it with a syringe. The US FDA has reported serious dosing errors from vials when units and millilitres were confused, so if you use a vial, get trained on video before your first dose.

How should I store semaglutide at home?

Follow the leaflet in your own pack. As a reference, the originator's US labels say pens are kept at 2 to 8°C before first use, never frozen, and protected from heat and light, and a multi-dose pen in use can be kept for up to 56 days at 15 to 30°C or in the fridge.

How can I tell if my semaglutide is fake?

Buy only against a prescription from a licensed pharmacy that gives you an invoice. Check that the batch and expiry match on the carton and the pen, that it arrived cold and sealed, and that the solution is clear and colourless. Be wary of unusual discounts and online marketplaces.

Dr. Mujeeb Afzal

Medically reviewed by

Dr. Mujeeb Afzal

MBBS, MD, DM (Endocrinology)Reg. No. 71516, Telangana State Medical Council

Dr. Mujeeb Afzal is a consultant endocrinologist (MBBS, MD, DM Endocrinology) on ALTRcare's senior medical team. He sees patients whose weight is tied up with hormones, thyroid disease, diabetes or PCOS, and reviews ALTRcare's clinical protocols for GLP-1 medicines.

Last reviewed 28 October 2026 · How we review our guides

Sources

  1. India's weight loss drug moment: What happens when semaglutide goes generic (Business Today, 20 March 2026)
  2. The GLP-1 Gold Rush Is Over: Why India's Generic Semaglutide Market Is Losing Momentum (Outlook Business, 29 June 2026)
  3. Eris, Natco Announce Launch of Generic Semaglutide Brands as Patent Expires (PTI) (Outlook Business, 20 March 2026)
  4. G.S.R. 922(E): Revised Schedule M, Good Manufacturing Practices (Ministry of Health and Family Welfare (via CDSCO), 28 December 2023)
  5. G.S.R. 127(E): Drugs (Amendment) Rules, 2025, extension for small and medium manufacturers (Ministry of Health and Family Welfare (via CDSCO), 11 February 2025)
  6. NSQ Alerts: drugs not of standard quality and spurious drugs (Central Drugs Standard Control Organisation)
  7. Alert on theft of multiple drug products of M/s Novo Nordisk during transit (Central Drugs Standard Control Organisation, 21 August 2025)
  8. Regulatory Surveillance Over Weight Loss Drug (GLP-1) Supply Chain (Press Information Bureau, Ministry of Health and Family Welfare, 24 March 2026)
  9. OZEMPIC (semaglutide) injection, US prescribing information (DailyMed, US National Library of Medicine)
  10. WEGOVY (semaglutide) injection, US prescribing information (DailyMed, US National Library of Medicine)
  11. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (US Food and Drug Administration, 26 July 2024)
  12. India seizes suspected fake Mounjaro pens, says raw materials sourced from Alibaba (Reuters) (Gulf Daily News, 20 April 2026)

Ready to take the next step?

Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed, with no obligation.

Free PDF guide

Your 3-month semaglutide plan, in seven pages

  • How semaglutide works and the 0.25 mg → 0.5 mg → 1 mg dose steps
  • Everything in the plan, Standard vs Premium, from ₹10,999 (₹3,666 a month)
  • What results look like, from the trials and from ALTRcare patients
  • Your four doctors, and what happens after month 3
+91

ALTRcare may message you once about starting. No spam, and you can say no.

This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.

Keep reading